Retinopathy Regression with Treat and Extend Ranibizumab for Diabetic Macular Edema

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Ophthalmology (Rochester, Minn.) Minn.), 2018-08, Vol.125 (8), p.1304-1306
Hauptverfasser:	Payne, John F., Clark, W. Lloyd, Bruce, Beau B., Wykoff, Charles C., Brown, David M., Menke, Brandon M., Iverson, Shawn M., Allen, Keri F., Boyer, David S., Wells, John A., Johnson, David L., Benz, Matthew, Chen, Eric, Fish, Richard H., Kim, Rosa Y., Major, James C., O’Malley, Ronan E., Schefler, Amy C., Shah, Ankoor R., Wong, Tien P., Novack, Roger L., Chu, Thomas G., Rahhal, Firas, Tabandeh, Homayoun, Roe, Richard H., Dayani, Pouya N., Liao, David, Walsh, Alexander, Esmaili, Daniel D.
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Inhibitors - administration & dosage Diabetic Retinopathy - complications Diabetic Retinopathy - diagnosis Diabetic Retinopathy - drug therapy Female Humans Intravitreal Injections Macular Edema - diagnosis Macular Edema - drug therapy Macular Edema - etiology Male Middle Aged Ranibizumab - administration & dosage Retina - pathology Tomography, Optical Coherence Treatment Outcome Vascular Endothelial Growth Factor A - antagonists & inhibitors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!